Penn-led trial shows AZEDRA can be effective, safe for treatment of rare neuroendocrine tumors
Credit: Penn Medicine PHILADELPHIA - A radiotherapy drug that treats the rare neuroendocrine cancers pheochromocytoma and paraganglioma can be both effective and safe for patients,...

 
 





